EA200400584A1 - Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов - Google Patents
Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответовInfo
- Publication number
- EA200400584A1 EA200400584A1 EA200400584A EA200400584A EA200400584A1 EA 200400584 A1 EA200400584 A1 EA 200400584A1 EA 200400584 A EA200400584 A EA 200400584A EA 200400584 A EA200400584 A EA 200400584A EA 200400584 A1 EA200400584 A1 EA 200400584A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- carbonilbenzoxazine
- strengthen
- brain
- treatment
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000946 synaptic effect Effects 0.000 title 1
- 210000004556 brain Anatomy 0.000 abstract 3
- 206010012289 Dementia Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000003920 cognitive function Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002996 emotional effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 210000000225 synapse Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение относится к предупреждению и лечению церебральной недостаточности, включающему увеличение рецепторов, функционирующих в синапсах в сетях мозга, отвечающих за поведение более высокого порядка. Эти сети мозга отвечают за когнитивные функции, относящиеся к расстройству памяти, которые наблюдаются при разных видах слабоумия, а также за дисбаланс нейрональной активности между различными областями мозга, возникающий при таких заболеваниях, как болезнь Паркинсона, шизофрения и эмоциональные заболевания. В частности, настоящее изобретение относится к соединениям, используемым для лечения таких состояний, а также способам применения этих соединений для такого лечения.Отчет о международном поиске был опубликован 2003.08.28.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33333401P | 2001-11-26 | 2001-11-26 | |
| PCT/US2002/037646 WO2003045315A2 (en) | 2001-11-26 | 2002-11-25 | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200400584A1 true EA200400584A1 (ru) | 2005-02-24 |
| EA011034B1 EA011034B1 (ru) | 2008-12-30 |
Family
ID=23302344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200400584A EA011034B1 (ru) | 2001-11-26 | 2002-11-25 | Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7799913B2 (ru) |
| EP (1) | EP1448537A4 (ru) |
| JP (1) | JP4620349B2 (ru) |
| KR (1) | KR100915176B1 (ru) |
| CN (1) | CN1620440A (ru) |
| AU (1) | AU2002352886B2 (ru) |
| BR (1) | BR0214425A (ru) |
| CA (1) | CA2463592A1 (ru) |
| CZ (1) | CZ2004632A3 (ru) |
| EA (1) | EA011034B1 (ru) |
| GE (1) | GEP20063859B (ru) |
| HR (1) | HRP20040424A2 (ru) |
| HU (1) | HUP0402279A3 (ru) |
| IL (1) | IL161452A0 (ru) |
| MA (1) | MA26233A1 (ru) |
| MX (1) | MXPA04004815A (ru) |
| NO (1) | NO20041590L (ru) |
| NZ (1) | NZ532368A (ru) |
| PL (1) | PL371722A1 (ru) |
| SK (1) | SK2292004A3 (ru) |
| UA (1) | UA79940C2 (ru) |
| WO (1) | WO2003045315A2 (ru) |
| ZA (1) | ZA200403729B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2144506T3 (pl) * | 2007-01-03 | 2012-04-30 | Servier Lab | 3-podstawiony-[1,2,3]-benzotriazynon jako związek do wzmacniania odpowiedzi glutaminianergicznych |
| AP2009004915A0 (en) * | 2007-01-03 | 2009-08-31 | Cortex Pharma Inc | 3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses |
| WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| AU2012267622B2 (en) | 2011-06-08 | 2017-06-22 | Sunovion Pharmaceuticals, Inc. | Metabotropic glutamate receptor 5 modulators and methods of use thereof |
| CA2915405A1 (en) | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
| CN107922403A (zh) | 2015-06-26 | 2018-04-17 | 武田药品工业株式会社 | 作为胆碱能毒蕈碱m1受体的调节剂的2,3‑二氢‑4h‑1,3‑苯并噁嗪‑4‑酮衍生物 |
| EP3366679B1 (en) | 2015-10-20 | 2021-03-24 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| CA3075477A1 (en) | 2017-08-07 | 2019-02-14 | Joint Stock Company "Biocad" | Novel heterocyclic compounds as cdk8/19 inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2943087A (en) * | 1960-06-28 | n naoh | ||
| DE1122531B (de) * | 1957-09-13 | 1962-01-25 | Thomae Gmbh Dr K | Verfahren zur Herstellung von therapeutisch wertvollen 4-Oxo-2-(halogenalkyl)-2,3-dihydro-benzoxazinen-(1,3) |
| US4022139A (en) | 1975-10-28 | 1977-05-10 | Blue Bell, Inc. | Tacker guide and method |
| EP0010348A1 (en) * | 1978-09-12 | 1980-04-30 | Imperial Chemical Industries Plc | Heterocyclic trichloromethyl derivatives, process for their preparation and their use |
| JPH0597824A (ja) * | 1990-09-25 | 1993-04-20 | Takeda Chem Ind Ltd | １，３−ベンゾオキサジン誘導体 |
| PT651746E (pt) * | 1992-07-24 | 2002-09-30 | Univ California | Drogas que intensificam as respostas sinapticas mediadas por receptores de ampa |
| US5650409A (en) | 1995-06-02 | 1997-07-22 | Cortex Pharmaceuticals, Inc. | Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| US5736543A (en) | 1996-04-03 | 1998-04-07 | The Regents Of The University Of California | Benzoxazines for enhancing synaptic response |
| GB9716962D0 (en) * | 1997-08-12 | 1997-10-15 | Univ Birmingham | Liver function test |
| US6130214A (en) * | 1997-10-27 | 2000-10-10 | Dr. Reddy's Research Foundation | Benzothiazin and benzoxazin derivatives; their preparation and uses |
| RU2214405C2 (ru) * | 1998-02-18 | 2003-10-20 | НьюроСёрч А/С | Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов |
| US6124278A (en) * | 1998-04-03 | 2000-09-26 | The Regents Of The University Of California | Acylbenzoxazines for enhancing synaptic response |
-
2002
- 2002-11-25 SK SK229-2004A patent/SK2292004A3/sk not_active Application Discontinuation
- 2002-11-25 IL IL16145202A patent/IL161452A0/xx unknown
- 2002-11-25 HU HU0402279A patent/HUP0402279A3/hu unknown
- 2002-11-25 EP EP02789846A patent/EP1448537A4/en not_active Withdrawn
- 2002-11-25 EA EA200400584A patent/EA011034B1/ru not_active IP Right Cessation
- 2002-11-25 CA CA002463592A patent/CA2463592A1/en not_active Abandoned
- 2002-11-25 UA UA20040503965A patent/UA79940C2/uk unknown
- 2002-11-25 NZ NZ532368A patent/NZ532368A/en not_active IP Right Cessation
- 2002-11-25 MX MXPA04004815A patent/MXPA04004815A/es active IP Right Grant
- 2002-11-25 JP JP2003546820A patent/JP4620349B2/ja not_active Expired - Fee Related
- 2002-11-25 KR KR1020047007502A patent/KR100915176B1/ko not_active IP Right Cessation
- 2002-11-25 CN CNA028234502A patent/CN1620440A/zh active Pending
- 2002-11-25 US US10/495,049 patent/US7799913B2/en not_active Expired - Fee Related
- 2002-11-25 CZ CZ2004632A patent/CZ2004632A3/cs unknown
- 2002-11-25 AU AU2002352886A patent/AU2002352886B2/en not_active Ceased
- 2002-11-25 WO PCT/US2002/037646 patent/WO2003045315A2/en active Application Filing
- 2002-11-25 BR BR0214425-5A patent/BR0214425A/pt not_active Application Discontinuation
- 2002-11-25 GE GE5593A patent/GEP20063859B/en unknown
- 2002-11-25 PL PL02371722A patent/PL371722A1/xx not_active Application Discontinuation
-
2004
- 2004-04-19 NO NO20041590A patent/NO20041590L/no not_active Application Discontinuation
- 2004-05-12 HR HR20040424A patent/HRP20040424A2/xx not_active Application Discontinuation
- 2004-05-14 ZA ZA200403729A patent/ZA200403729B/en unknown
- 2004-05-21 MA MA27691A patent/MA26233A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003045315A3 (en) | 2003-08-28 |
| SK2292004A3 (en) | 2004-09-08 |
| MA26233A1 (fr) | 2004-07-01 |
| CA2463592A1 (en) | 2003-06-05 |
| US7799913B2 (en) | 2010-09-21 |
| ZA200403729B (en) | 2005-05-19 |
| WO2003045315A2 (en) | 2003-06-05 |
| AU2002352886A1 (en) | 2003-06-10 |
| US20040259871A1 (en) | 2004-12-23 |
| MXPA04004815A (es) | 2005-02-17 |
| JP2005510532A (ja) | 2005-04-21 |
| KR20040054777A (ko) | 2004-06-25 |
| HUP0402279A2 (hu) | 2005-02-28 |
| JP4620349B2 (ja) | 2011-01-26 |
| CN1620440A (zh) | 2005-05-25 |
| KR100915176B1 (ko) | 2009-09-03 |
| EP1448537A2 (en) | 2004-08-25 |
| NO20041590L (no) | 2004-07-12 |
| HRP20040424A2 (en) | 2005-06-30 |
| HUP0402279A3 (en) | 2008-09-29 |
| IL161452A0 (en) | 2004-09-27 |
| PL371722A1 (en) | 2005-06-27 |
| EP1448537A4 (en) | 2005-05-04 |
| NZ532368A (en) | 2006-10-27 |
| CZ2004632A3 (cs) | 2004-08-18 |
| EA011034B1 (ru) | 2008-12-30 |
| BR0214425A (pt) | 2004-11-03 |
| UA79940C2 (en) | 2007-08-10 |
| GEP20063859B (en) | 2006-06-26 |
| AU2002352886B2 (en) | 2008-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900937A1 (ru) | Соединения 3-замещенного-[1,2,3]бензотриазинона для усиления глутаматергических синаптических ответов | |
| ATE226206T1 (de) | Benzoxazine zur erhöhung der synaptischen reaktionen | |
| PT839134E (pt) | Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica | |
| EA200900925A1 (ru) | 3-замещённое-[1,2,3]-бензотриазиноновое соединение для увеличения глутаматергических синаптических ответов | |
| DE69942175D1 (de) | Beidäugige ermittlung der von einer krankheit betroffenen bereiche der sehnerven und des sehzentrums | |
| NO993768L (no) | Benzofuranforbindelser som forbedrer AMPA-reseptoraktivitet | |
| EA200400584A1 (ru) | Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов | |
| ATE261306T1 (de) | Benzoxazin-derivate zur erhöhung der synaptischen reaktion | |
| PT1067935E (pt) | Acilbenzoxazinas para melhorar resposta (s) sinaptica (s) | |
| WO2005061002A3 (en) | Composition and methods for modulating cns activity | |
| UA93306C2 (ru) | Соединение 3-замещенного-[1,2,3]-бензотриазинона для улучшения глутаматергических синаптических реакций |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |